Skip to content

Mindfulness-Oriented Recovery Enhancement for Addictive Behavior, Psychiatric Distress, and Chronic Pain: A Multilevel Meta-Analysis of Randomized Controlled Trials.

Anna Parisi, R Lynae Roberts, Adam W. Hanley, Eric L Garland

Mindfulness September 15, 2022 DOI: 10.1007/s12671-022-01964-x (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Meta-analysis Randomized Peer reviewed
Sample size 816
Population Participants in eight randomized controlled trials of Mindfulness-Oriented Recovery Enhancement
Intervention Mindfulness-Oriented Recovery Enhancement (MORE)
Topics Addiction Meditation
Keywords Chronic pain Opioids Mental health Substance use disorders
Key findings Across eight randomized controlled trials (N=816), Mindfulness-Oriented Recovery Enhancement showed small to moderate benefits for addictive behaviors, craving, opioid dose, chronic pain, and psychiatric symptoms, with effects on psychiatric symptoms and craving not moderated by race, gender, age, or income. The authors argue that MORE is efficacious across diverse individuals and should be disseminated broadly in healthcare.

Abstract

Objectives: Mindfulness-Oriented Recovery Enhancement (MORE) is an integrative intervention designed to ameliorate addiction, chronic pain, and psychiatric symptoms. Although multiple randomized controlled trials (RCTs) have examined the clinical efficacy of MORE, no study has quantitatively synthesized this body of research. Thus, we conducted a meta-analysis of RCTs examining the effects of MORE on addictive behaviors, craving, opioid dose, pain, and psychiatric symptoms.

Methods: Relevant manuscripts were identified through comprehensive searches of four bibliographic databases. Two- and three-level random-effects models were used to generate synthesized effect size estimates, and meta-regressions were performed to examine whether study and sample characteristics influenced the magnitude of aggregate effect sizes.

Results: Our search identified 16 manuscripts reporting data from eight RCTs (N = 816). Moderate to small effects in favor of MORE were observed for addictive behaviors (SMC = - .54, p = .007), craving (SMC = - .42, p = .010), opioid dose (MC = - 17.95, p < .001), chronic pain (SMC = - .60, p < .001), and psychiatric symptoms (SMC = - .34, p < .001). MORE's effects on psychiatric symptoms and craving were not moderated by participant race, gender, age, or income.

Conclusions: Study findings provide empirical evidence of MORE's efficacy for a wide diversity of individuals, and as such, MORE should now be disseminated broadly throughout the healthcare system. Meta-analysis pre-registration prospero #crd42022319006: Supplementary information: The online version contains supplementary material available at 10.1007/s12671-022-01964-x.

Comparable studies

Other systematic reviews and meta-analyses on meditation, most cited first.

Study Year Design Participants
Meditation Programs for Psychological Stress and Well-being Diverse adult clinical populations 2014 Meta-analysis n = 3,515
Mindfulness-Based Stress Reduction for Stress Management in Healthy People: A Review and Meta-Analysis Healthy subjects 2009 Systematic review and meta-analysis
The psychological effects of meditation: A meta-analysis. Nonclinical groups of adult meditators 2012 Meta-analysis n = 163
Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse Adults with recurrent depression in full or partial remission 2016 Meta-analysis of individual patient data from randomized controlled trials n = 1,258
Mindfulness‐Based Stress Reduction and Mindfulness‐Based Cognitive Therapy – a systematic review of randomized controlled trials 2011 Systematic review

Citations in the library

Cited by 28

and 23 more in the library

Cites 19

and 14 more in the library

Explore topics